 Home > Active Ingredient News > Digestive System Information > Express 40% of patients can reduce liver fat content by more than 30%! The nash new drug is expected to advance to the Clinical Phase 3 trial

Express 40% of patients can reduce liver fat content by more than 30%! The nash new drug is expected to advance to the Clinical Phase 3 trial

 Last Update: 2022-09-15
 Source: Internet
 Author: User

▎ WuXi AppTec content team editor

Poxel has announced the positive apex results

Image source: Poxel official website

DESTINY-1 is a 36-week randomized, dose-ranged, double-blind, placebo-controlled, parallel phase 2 trial

▲If you have any business needs, please long press to scan the QR code above, or

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Dimethicone

CAS No.: 9006-65-9

Different Grade

$0.1/KG EXW

Wholesale Magnesium Oxide Raw Materials CAS 1309-48-4 99% Powder Evergreen EGC-Magnesium Oxide Powder

CAS No.: 1309-48-4

Food Grade

$70-76/KG FOB

USP Grade Transparent Pure 97% 98% 99.5% 99.7% 99.9% Refined Glycerine 99.7% colorless viscous liquid

CAS No.: 56-81-5

Food Grade

$800/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.